Since February is designated Age-Related Macular Degeneration Awareness month. For healthcare providers, there are numerous resources available to help promote awareness to patients and to encourage patients to continue (or start) annual visual exams.
Anti-VEGF treatment has undoubtedly revolutionized how ophthalmologists manage patients with AMD. But have we leveled out? And, more importantly, how do we break through the plateau?